Cornerstone Wealth Group LLC Raises Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Cornerstone Wealth Group LLC raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.8% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 12,040 shares of the healthcare conglomerate’s stock after purchasing an additional 209 shares during the period. Cornerstone Wealth Group LLC’s holdings in UnitedHealth Group were worth $7,040,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in UNH. Tealwood Asset Management Inc. bought a new position in shares of UnitedHealth Group in the 3rd quarter valued at about $2,905,000. Asset Planning Services Inc. LA ADV lifted its holdings in shares of UnitedHealth Group by 1.2% in the 3rd quarter. Asset Planning Services Inc. LA ADV now owns 12,465 shares of the healthcare conglomerate’s stock valued at $7,288,000 after acquiring an additional 150 shares during the last quarter. Vantage Investment Partners LLC increased its position in shares of UnitedHealth Group by 42.2% during the first quarter. Vantage Investment Partners LLC now owns 152,107 shares of the healthcare conglomerate’s stock worth $75,247,000 after acquiring an additional 45,173 shares during the period. Sequoia Financial Advisors LLC increased its position in shares of UnitedHealth Group by 13.7% during the third quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate’s stock worth $14,603,000 after acquiring an additional 3,006 shares during the period. Finally, Maryland State Retirement & Pension System boosted its stake in UnitedHealth Group by 0.6% in the first quarter. Maryland State Retirement & Pension System now owns 72,689 shares of the healthcare conglomerate’s stock valued at $35,126,000 after acquiring an additional 469 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.3 %

UNH opened at $563.71 on Thursday. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $608.63. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a 50-day moving average price of $582.60 and a 200 day moving average price of $540.48. The company has a market cap of $520.54 billion, a PE ratio of 36.72, a price-to-earnings-growth ratio of 1.66 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter in the prior year, the company posted $6.56 EPS. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. Sell-side analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.49%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Analyst Ratings Changes

UNH has been the subject of several recent analyst reports. Robert W. Baird raised their target price on shares of UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research note on Wednesday, July 17th. HSBC downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 17th. Royal Bank of Canada lowered their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. Barclays lowered their price objective on shares of UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating for the company in a research note on Tuesday, October 22nd. Finally, Argus lifted their price objective on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Four analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $615.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.